apomorphine has been researched along with lead in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Rossett, SE; Drew, WG; Kostas, J; McFarland, DJ | 1 |
| Cory-Slechta, DA; Widzowski, DV | 1 |
| Beuthin, FC; Louis-Ferdinand, RT; Rosen, JB; Young, AM | 1 |
| Dehaven, DL; Schulz, DW; Tilson, HA; Walsh, TJ | 1 |
| Cory-Slechta, DA; Pokora, MJ; Richfield, EK | 1 |
| Cory-Slechta, DA; McCoy, L; Richfield, EK | 1 |
| Pitts, DK; Tavakoli-Nezhad, M | 1 |
7 other study(ies) available for apomorphine and lead
| Article | Year |
|---|---|
Effects of neonatal lead exposure on apomorphine-induced aggression and stereotypy in the rat.
Topics: Aggression; Animals; Animals, Newborn; Apomorphine; Behavior; Female; Growth; Humans; Lactation; Lead; Male; Milk; Pregnancy; Rats; Stereotyped Behavior | 1979 |
Low level lead exposure increases sensitivity to the stimulus properties of dopamine D1 and D2 agonists.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Behavior, Animal; Cocaine; Dextroamphetamine; Discrimination Learning; Dizocilpine Maleate; Dopamine Agents; Drug Synergism; Ergolines; Generalization, Psychological; Haloperidol; Lead; Male; Morphine; N-Methylaspartate; Pentobarbital; Quinpirole; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Opioid; Receptors, Opioid, mu | 1991 |
Discriminative stimulus properties of amphetamine and other stimulants in lead-exposed and normal rats.
Topics: Amphetamine; Animals; Apomorphine; Body Weight; Caffeine; Central Nervous System Stimulants; Discrimination, Psychological; Dose-Response Relationship, Drug; Generalization, Stimulus; Lead; Lead Poisoning; Male; Methylphenidate; Rats | 1986 |
Acute exposure to triethyl lead enhances the behavioral effects of dopaminergic agonists: involvement of brain dopamine in organolead neurotoxicity.
Topics: Animals; Apomorphine; Brain Diseases; Dextroamphetamine; Dopamine; Drug Interactions; Lead; Male; Motor Activity; Organometallic Compounds; Rats; Rats, Inbred F344; Stereotyped Behavior | 1986 |
Preferential vulnerability of nucleus accumbens dopamine binding sites to low-level lead exposure: time course of effects and interactions with chronic dopamine agonist treatments.
Topics: Administration, Oral; Animals; Apomorphine; Benzazepines; Binding Sites; Carrier Proteins; Dopamine; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Kinetics; Lead; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Nucleus Accumbens; Organometallic Compounds; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Time Factors | 1996 |
Time course and regional basis of Pb-induced changes in MK-801 binding: reversal by chronic treatment with the dopamine agonist apomorphine but not the D1 agonist SKF-82958.
Topics: Animals; Apomorphine; Benzazepines; Dizocilpine Maleate; Dopamine Agonists; Drug Administration Schedule; Lead; Male; Osmolar Concentration; Rats; Rats, Inbred Strains; Receptors, Dopamine D1; Time Factors; Tissue Distribution | 1997 |
Postnatal inorganic lead exposure reduces midbrain dopaminergic impulse flow and decreases dopamine D1 receptor sensitivity in nucleus accumbens neurons.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Growth; Haloperidol; Immunohistochemistry; Lead; Male; Mesencephalon; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Tyrosine 3-Monooxygenase; Ventral Tegmental Area | 2005 |